Prognostic value of albuminuria on 1-month mortality in acute myocardial infarction

American Heart Journal

Volumn 157, Issue 2, 2009, Pages 327-333

  Schiele, François ^a   Meneveau, Nicolas ^a   Chopard, Romain ^a   Descotes Genon, Vincent ^a   Oettinger, Joanna ^a   Seronde, Marie France ^a   Briand, Florent ^a   Bernard, Yvette ^a   Ecarnot, Fiona ^a   Bassand, Jean Pierre ^a  

^a UNIVERSITY HOSPITAL JEAN MINJOZ   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ALBUMIN; ANTICOAGULANT AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BRAIN NATRIURETIC PEPTIDE; C REACTIVE PROTEIN; CLOPIDOGREL; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLUCOSE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; TROPONIN;

ACUTE HEART INFARCTION; ADULT; AGED; AGING; ALBUMINURIA; ANGIOGRAPHY; ARTICLE; FEMALE; HOSPITAL CARE; HUMAN; IMMUNONEPHELOMETRY; INCREMENTAL PREDICTIVE VALUE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; NEPHELOMETRY; PERIPHERAL VASCULAR DISEASE; PREDICTION; PREDICTIVE VALIDITY; PRIORITY JOURNAL; PROGNOSIS; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; URINALYSIS;

ALBUMINURIA; FEMALE; FRANCE; HUMANS; MALE; MYOCARDIAL INFARCTION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REGISTRIES; RISK ASSESSMENT;

EID: 58649108971     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2008.09.018     Document Type: Article

References (21)

1. National Kidney Foundation. National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39 2 Suppl 1 (2002) S1-S266
2. Viberti G.C., Hill R.D., Jarrett R.J., et al. Microalbuminuria as a predictor of clinical nephropathy in insulin-dependent diabetes mellitus. Lancet 1 (1982) 1430-1432
3. Gerstein H.C., Mann J.F., Yi Q., et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 286 (2001) 421-426
4. Yudkin J.S., Forrest R.D., and Jackson C.A. Microalbuminuria as predictor of vascular disease in non-diabetic subjects. Islington Diabetes Survey. Lancet 2 (1988) 530-533
5. Romundstad S., Holmen J., Kvenild K., et al. Microalbuminuria and all-cause mortality in 2,089 apparently healthy individuals: a 4.4-year follow-up study. The Nord-Trondelag Health Study (HUNT), Norway. Am J Kidney Dis 42 (2003) 466-473
6. Gosling P., Hughes E.A., Reynolds T.M., et al. Microalbuminuria is an early response following acute myocardial infarction. Eur Heart J 12 (1991) 508-513
7. Berton G., Citro T., Palmieri R., et al. Albumin excretion rate increases during acute myocardial infarction and strongly predicts early mortality. Circulation 96 (1997) 3338-3345
8. Berton G., Cordiano R., Palmieri R., et al. Microalbuminuria during acute myocardial infarction; a strong predictor for 1-year mortality. Eur Heart J 22 (2001) 1466-1475
9. Koulouris S., Lekatsas I., Karabinos I., et al. Microalbuminuria: a strong predictor of 3-year adverse prognosis in nondiabetic patients with acute myocardial infarction. Am Heart J 149 (2005) 840-845
10. Berton G., Cordiano R., Palmieri R., et al. Albumin excretion in diabetic patients in the setting of acute myocardial infarction: association with 3-year mortality. Diabetologia 47 (2004) 1511-1518
11. Lekatsas I., Koulouris S., Triantafyllou K., et al. Prognostic significance of microalbuminuria in non-diabetic patients with acute myocardial infarction. Int J Cardiol 106 (2006) 218-223
12. Cook N.R. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 115 (2007) 928-935
13. DeLong E.R., DeLong D.M., and Clarke-Pearson D.L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44 (1988) 837-845
14. Song H.H. Analysis of correlated ROC areas in diagnostic testing. Biometrics 53 (1997) 370-382
15. Granger C.B., Goldberg R.J., Dabbous O., et al. Predictors of hospital mortality in the global registry of acute coronary events. Arch Intern Med 163 (2003) 2345-2353
16. Bassand J.P., Hamm C.W., Ardissino D., et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. Eur Heart J 28 (2007) 1598-1660
17. Anderson J.L., Adams C.D., Antman E.M., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 50 (2007) e1-e157
18. Blankenberg S., McQueen M.J., Smieja M., et al. Comparative impact of multiple biomarkers and N-terminal pro-brain natriuretic peptide in the context of conventional risk factors for the prediction of recurrent cardiovascular events in the Heart Outcomes Prevention Evaluation (HOPE) Study. Circulation 114 (2006) 201-208
19. Gosling P., Czyz J., Nightingale P., et al. Microalbuminuria in the intensive care unit: clinical correlates and association with outcomes in 431 patients. Crit Care Med 34 (2006) 2158-2166
20. Ridker P.M. Inflammatory biomarkers and risks of myocardial infarction, stroke, diabetes, and total mortality: implications for longevity. Nutr Rev 65 12 Pt 2 (2007) S253-S259
21. Kruk M., Przyluski J., Kalinczuk L., et al. Association of non-specific inflammatory activation with early mortality in patients with ST-elevation acute coronary syndrome treated with primary angioplasty. Circ J 72 (2008) 205-211